Granisetron Hydrochloride

盐酸格拉司琼

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGranisetron Hydrochloride
Drug Alias NameGranisetronum Hydrochloride格拉司琼盐酸盐盐酸格兰西龙Granisetron-MDTSBEMA-Granisetron +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor antagonists
TargetsSerotonin (5-HT) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingVomitingNausea +[4] 
Global Approved IndicationsVomitingNausea
Approved Indications in ChinaVomitingNausea
Original Approved Country/TerritoryUnited States
Original Approved Date1993/12/29
Country/TerritoryCanadaUnited StatesHong Kong +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSolasia Pharma KkFuan Pharmaceutical Group Ningbo Team Pharmaceutical Co Ltd
Inactive CompaniesInstitute Of Toxicants And Drugs, Academy Of Military Medical Sciences, Chinese People'S Liberation ArmyF. Hoffmann-La Roche LtdTeva Pharmaceuticals Usa Inc +[6] 
Active IndicationsVomitingNausea
Inactive IndicationsChemotherapy-induced nausea and vomitingCarcinoma

Other Information

ATC CodeA04AA02
Related LinksWikipediaDrugBankKEGG